An easy way of publishing your relevant EU press releases.

Medicines for Europe

Press Releases of this organisation

Biosimilar medicines have delivered 18BN€ total savings for Europe but more action needed to translate this potential into patient access and sustainable health systems Medicines for Europe 16 Dec 2021 Health & Consumers
Commission study highlights market framework conditions are main driver for medicines shortages Medicines for Europe 10 Dec 2021 Health & Consumers
Access to essential medicines threatened by combination of increasing inflation and potential further price cuts in EU countries Medicines for Europe 26 Nov 2021 Health & Consumers
European Parliament report calls for increased use of off-patent medicines to improve patient access Medicines for Europe 25 Nov 2021 Health & Consumers
The EU must stop the offshoring of essential medicines manufacturing investments: ambitious, open and coherent policies must support competitive, robust and sustainable production of APIs and medicines Medicines for Europe 23 Nov 2021 Global Europe
Adjustments to IP framework needed to improve access to medicines in Europe Medicines for Europe 16 Nov 2021 Science & Policymaking
Access to medicines critical in European Parliament vote on EU IP action plan Medicines for Europe 12 Nov 2021 Health & Consumers
EU must learn from Covid-19 to improve crisis preparedness and response for the future Medicines for Europe 09 Nov 2021 Health & Consumers
European Commission pilot project on repurposing brings value added innovation to life Medicines for Europe 28 Oct 2021 Health & Consumers
Baton passes from Christoph Stoller to Rebecca Guntern as President of Medicines for Europe Medicines for Europe 01 Oct 2021 Health & Consumers
HERA must address outstanding weaknesses in EU pharma framework to be successful Medicines for Europe 16 Sep 2021 Health & Consumers
Orphan and paediatric reform should strive to improve access to medicine for rare disease patients and children Medicines for Europe 30 Jul 2021 Health & Consumers
EU must take the lead to ensure security of supply for medicines Medicines for Europe 16 Jun 2021 Health & Consumers
Open borders that prioritise essential goods key to medicines supply in Europe Medicines for Europe 02 Jun 2021 Health & Consumers
EU Industrial strategy should be key to improving medicines supply chains Medicines for Europe 17 May 2021 Health & Consumers
Off patent medicines essential for a fairer, healthier, and sustainable Europe says President Christoph Stoller Medicines for Europe 30 Apr 2021 Health & Consumers
European patients need improved access to biosimilar medicines Medicines for Europe 22 Apr 2021 Health & Consumers
New report assesses progress on biosimilar medicine policies across Europe Medicines for Europe 30 Mar 2021 Health & Consumers
EU industrial policy can dramatically improve medicines manufacturing resilience and security of supply Medicines for Europe 17 Mar 2021 Health & Consumers
New report reveals need for pricing and reimbursement and procurement reforms to ensure patient access and healthcare sustainability Medicines for Europe 01 Mar 2021 Health & Consumers
Smart policies will encourage more critical medicines manufacturing in Europe Medicines for Europe 26 Feb 2021 Health & Consumers
EU must address barriers to continuous off-patent innovation and grasp opportunity for patients and healthcare Medicines for Europe 23 Feb 2021 Health & Consumers
A new medicines trade and health security agenda for the European Commission Medicines for Europe 19 Feb 2021 Health & Consumers
No further excuse to delay digital regulatory infrastructure for medicines after COVID-19 pandemic Medicines for Europe 19 Feb 2021 Health & Consumers
Smarter use of generic, biosimilar and value added medicines will ensure equitable access to cancer care Medicines for Europe 04 Feb 2021 Health & Consumers
AESGP, EFPIA and Medicines for Europe reflections on the European Medicines Agency, the Heads of Medicines Agencies and the European Commission “Key principles for the use of electronic product information for EU medicines” Medicines for Europe 03 Feb 2021 Health & Consumers
Window of opportunity to enhance EU regulatory systems wide open as EU pharma strategy prioritises stronger EU networks Medicines for Europe 19 Jan 2021 Health & Consumers
EU digital strategy requires investments in the digitalisation of Europe’s medicines regulatory agencies to succeed Medicines for Europe 15 Jan 2021 Health & Consumers
EU pharma strategy success depends on access to generic, biosimilar and value added medicines Medicines for Europe 25 Nov 2020 Health & Consumers
European Health Union – first step to greater EU solidarity in health crisis situations Medicines for Europe 11 Nov 2020 Health & Consumers